References from scientific journals

Ampicillin.

[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1990;50:153-67. IARC Monogr Eval Carcinog Risks Hum. 1990. PMID: 2292797 Free PMC article. Review. No abstract available.


[Ampicillin--pivampicillin--amoxicillin].

Rollag H, Melby K. Rollag H, et al. Tidsskr Nor Laegeforen. 1977 Nov 30;97(33):1759-60. Tidsskr Nor Laegeforen. 1977. PMID: 244370 Norwegian. No abstract available.


Ampicillin.

Jusko WJ. Jusko WJ. J Am Pharm Assoc. 1975 Oct;15(10):591-4. doi: 10.1016/s0003-0465(16)34104-0. J Am Pharm Assoc. 1975. PMID: 1184921 No abstract available.


The pharmacokinetics of bacampicillin.

Neu HC. Neu HC. Rev Infect Dis. 1981 Jan-Feb;3(1):110-6. doi: 10.1093/clinids/3.1.110. Rev Infect Dis. 1981. PMID: 7012993 Review.

Bacampicillin is an ethoxycarbonyloxyethyl ester of ampicillin that is rapidly converted to free ampicillin, the active agent, by nonspecific esterases present in serum and in the intestinal wall. ...Recovery of ampicillin in urine after ingestion of bacampic …
Bacampicillin is an ethoxycarbonyloxyethyl ester of ampicillin that is rapidly converted to free ampicillin, the active agent, …

[Bacampicillin].

Mashimo K. Mashimo K. Jpn J Antibiot. 1982 Dec;35(12):2723-35. Jpn J Antibiot. 1982. PMID: 6763634 Review. Japanese. No abstract available.


Bacampicillin hydrochloride: chemistry, pharmacology, and clinical use.

Scheife RT, Neu HC. Scheife RT, et al. Pharmacotherapy. 1982 Nov-Dec;2(6):313-21. doi: 10.1002/j.1875-9114.1982.tb03206.x. Pharmacotherapy. 1982. PMID: 6762528 Review.

Bacampicillin hydrochloride is an orally administered ester of ampicillin that is rapidly and completely hydrolyzed in vivo to ampicillin. The most notable advantage of bacampicillin over ampicillin is its superior bioavailability--bacampicillin achieves sign …
Bacampicillin hydrochloride is an orally administered ester of ampicillin that is rapidly and completely hydrolyzed in vivo to amp …

Ampicillin-mediated functionalized gold nanoparticles against ampicillin-resistant bacteria: strategy, preparation and interaction studies.

Chavan C, Kamble S, Murthy AVR, Kale SN. Chavan C, et al. Nanotechnology. 2020 May 22;31(21):215604. doi: 10.1088/1361-6528/ab72b4. Epub 2020 Feb 4. Nanotechnology. 2020. PMID: 32018229

This approach not only utilizes the maximum efficiency of nanoparticles and antibiotics towards ampicillin sensitive bacterial cells but also proves to be effective against ampicillin resistance bacteria. Our results illustrate that the optimized system of Amp-Au NP …
This approach not only utilizes the maximum efficiency of nanoparticles and antibiotics towards ampicillin sensitive bacterial cells …

Talampicillin.

[No authors listed] [No authors listed] Drug Ther Bull. 1976 Mar 26;14(7):27-8. Drug Ther Bull. 1976. PMID: 1253699 No abstract available.


Ampicillin and its congener prodrugs in the horse.

Sarasola P, McKellar QA. Sarasola P, et al. Br Vet J. 1994 Mar-Apr;150(2):173-87. doi: 10.1016/S0007-1935(05)80225-8. Br Vet J. 1994. PMID: 8025849 Review.

Ampicillin is an antibiotic commonly administered to horses by both the intramuscular (i.m.) and the intravenous (i.v.) route. ...Ampicillin may also be maintained in the equine body, for a prolonged period of time when administered as an i.v. infusion. ...
Ampicillin is an antibiotic commonly administered to horses by both the intramuscular (i.m.) and the intravenous (i.v.) route. ... …

Chryso-lactams:Gold(I) derivatives of ampicillin with specific activity against Gram-positive pathogens.

Michaut M, Steffen A, Contreras JM, Morice C, Paulen A, Schalk IJ, Plésiat P, Mislin GLA. Michaut M, et al. Bioorg Med Chem Lett. 2020 May 1;30(9):127098. doi: 10.1016/j.bmcl.2020.127098. Epub 2020 Mar 7. Bioorg Med Chem Lett. 2020. PMID: 32173196 No abstract available.